Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hemifacial spasm: The past, present and future.

Literature DB >> 26111430

Hemifacial spasm: The past, present and future.

Neera Chaudhry¹, Abhilekh Srivastava², Laxmikant Joshi¹.

Abstract

Hemifacial spasm is characterised by unilateral contractions of the facial muscles. Though considered to be benign by many people, it can lead to functional blindness and a poor quality of life due to social embarrassment for the suffering individual. Botulinum toxin therapy is an excellent noninvasive tool to treat this condition. However, surgical decompression of the aberrant vessel is also an upcoming approach to therapy for this condition.

Entities: Disease Species

Keywords: Botulinum toxin therapy; Differential diagnosis; Hemifacial spasm; Movement disorder; Pathogenesis; Review; Surgical treatment

Mesh：

Substances：
Botulinum Toxins

Year: 2015 PMID： 26111430 DOI： 10.1016/j.jns.2015.06.032

Source DB: PubMed Journal: J Neurol Sci ISSN： 0022-510X Impact factor: 3.181

Keyword Cloud
Cited

26 in total

1. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.

Authors: Libin Xiao; Yougui Pan; Xiaolong Zhang; Yong Hu; Li Cai; Zhiyu Nie; Lizhen Pan; Bing Li; Yijing He; Lingjing Jin
Journal: Neurol Sci Date: 2016-07-18 Impact factor: 3.307

2. Botulinum toxin therapy of hemifacial spasm: bilateral injections can reduce facial asymmetry.

Authors: Libin Xiao; Lizhen Pan; Bing Li; Yanwen Zhou; Yougui Pan; Xiaolong Zhang; Yong Hu; Dirk Dressler; Lingjing Jin
Journal: J Neurol Date: 2018-07-09 Impact factor: 4.849

3. Association study of the pneumatization degree of mastoid air cells and postoperative complications after microvascular decompression in hemifacial spasm.

Authors: Jianxin Zhou; Quanhong Shi; Li Jiang; Yanfeng Xie; Bo Deng; Yan Zhan
Journal: Acta Neurochir (Wien) Date: 2022-02-21 Impact factor: 2.216

4. A Review of Tolerance and Safety Profiles of Long-Term Botulinum Neurotoxin Type A in Asian Patients with Hemifacial Spasm and Benign Essential Blepharospasm.

Authors: Kenneth Ka Hei Lai; Alan Tsang; Andrew K T Kuk; Callie K L Ko; Edwin Chan; Simon T C Ko
Journal: Neuroophthalmology Date: 2021-05-19

10. Strengthened thalamoparietal functional connectivity in patients with hemifacial spasm: a cross-sectional resting-state fMRI study.

Authors: Xuan Niu; Hui Xu; Chenguang Guo; Tong Yang; Dustin Kress; Lin Gao; Shaohui Ma; Ming Zhang; Yuan Wang
Journal: Br J Radiol Date: 2020-01-16 Impact factor: 3.039

Hemifacial spasm: The past, present and future.

1. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.

2. Botulinum toxin therapy of hemifacial spasm: bilateral injections can reduce facial asymmetry.

3. Association study of the pneumatization degree of mastoid air cells and postoperative complications after microvascular decompression in hemifacial spasm.

4. A Review of Tolerance and Safety Profiles of Long-Term Botulinum Neurotoxin Type A in Asian Patients with Hemifacial Spasm and Benign Essential Blepharospasm.

5. Electroacupuncture on Hemifacial Spasm and Temporomandibular Joint Pain Co-Morbidity: A Case Report.

Review 6. Hearing Loss following Posterior Fossa Microvascular Decompression: A Systematic Review.

7. Abnormal brain white matter in patients with hemifacial spasm: a diffusion tensor imaging study.

8. Analysis of blink activity and anomalous eyelid movements in patients with hemifacial spasm.

9. Vascular tortuosity in relationship with hypertension and posterior fossa volume in hemifacial spasm.

10. Strengthened thalamoparietal functional connectivity in patients with hemifacial spasm: a cross-sectional resting-state fMRI study.